IP Library › Granted Patent US 12,728,189
Granted Patent B2
US 12,728,189 · App. 18/262,604 · Granted Sep 8, 2026

Systems and methods for generating AC volume recommendation for plasma collection

Inventor: Kyungyoon Min (Kildeer, IL)
Assignee: Fenwal, Inc.
A61M1/3496A61M1/361
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,728,189
App. No.
18/262,604
Granted
Sep 8, 2026
Kind
B2
Abstract

A method for determining a total volume of anticoagulant required for performing a plasmapheresis procedure prior to connecting the donor to the fluid flow circuit, by determining: a total blood volume for a donor, volume of plasma to be collected, a volume of anticoagulant that will be collected together with the plasma and estimating a separation efficiency for the blood separator. Then calculating volume of anticoagulant to be returned to the donor based on the separation efficiency, total volume of anticoagulant to be used and suggesting and attaching either a single container or multiple containers of anticoagulant based on said calculations. The system comprises a touch screen for receiving input and providing said calculation of a total volume of anticoagulant needed for the procedure, and recommendation the number of containers of anticoagulant needed.

Claims (35)

1 . A method for performing plasmapheresis using a fluid flow circuit and a blood separator, comprising:

a) determining a total blood volume (TBV) for a donor;

b) determining a volume of plasma (V P ) to be collected from the donor based on donor-specific characteristics;

c) determining a volume of anticoagulant (V ACP ) that will be collected together with the volume of plasma V P ;

d) calculating a volume of anticoagulant to be returned to the donor (V ACR ) based on a separation efficiency for the blood separator;

e) calculating a total volume of anticoagulant (V ACT ) to be used; and

f) preparing one or more containers of anticoagulant for attachment to the fluid flow circuit containing in total at least V ACT , or attaching a single container of anticoagulant to the fluid flow circuit containing at least V ACT ;

g) wherein steps a)-g) are performed prior to connecting the donor to the fluid flow circuit.

2 . The method of claim 1 , wherein the donor-specific characteristics comprise weight and hematocrit.

3 . The method of claim 2 , wherein the hematocrit is a default value.

4 . The method of claim 3 , wherein the default value for the hematocrit is representative of a worst-case scenario.

5 . The method of claim 4 , wherein the default value for the hematocrit is 54%.

6 . The method of claim 2 , wherein the hematocrit of the donor is measured.

7 . The method of claim 1 , wherein the donor-specific characteristics comprise weight, height, and hematocrit.

8 . The method of claim 1 , wherein the donor-specific variables comprise weight, height, gender, and hematocrit.

9 . The method of claim 1 wherein the one or more containers or the single container contain 250 ml of anticoagulant, if V ACT <250 mL; 500 ml of anticoagulant, if 250 mL<V ACT <500 mL; 750 ml of anticoagulant, if 500 mL<V ACT <750 ML; and 1000 mL of anticoagulant, if 750 mL<V ACT <1000 mL.

10 . The method of claim 1 , wherein V ACP =V P /(1+ACR*(1−Hct/100)); wherein ACR is a ratio of anticoagulant to whole blood and Het is a hematocrit of the donor.

11 . The method of claim 1 wherein a separation efficiency for the blood separator is determined based, at least in part, on a hematocrit of the donor.

12 . The method of claim 1 wherein the separation efficiency for the blood separator is based, at least in part, on a ratio of anticoagulant to whole blood (ACR) to be used.

13 . The method of claim 1 wherein V ACT =V ACP +V ACR .

14 . The method of claim 11 wherein V ACT is determined based on an estimated volume of whole blood to be processed to reach the volume of plasma to be collected, V P , and the separation efficiency.

15 . The method of claim 1 wherein V ACT additionally includes a volume of anticoagulant to be used for priming the fluid flow circuit and blood separator.

16 . The method of claim 1 wherein V ACT is increased to provide a margin of safety.

17 . The method of claim 15 , wherein V ACT is increased to provide a margin of safety.

18 . The method of claim 17 , wherein V ACT is increased by from 25 mL to 50 mL.

19 . The method of claim 1 further comprising comparing V ACT to an inventory of containers of anticoagulant and, determining whether V ACT is greater than a volume of anticoagulant in the inventory.

20 . An automated system for separating plasma from whole blood comprising a disposable fluid flow circuit including a separator for separating whole blood into a plasma fraction and a concentrated cell fraction and a reusable hardware component comprising a programmable controller having a touch screen for receiving input from an operator and configured to provide, based on operator input, a calculation of a total volume of anticoagulant needed for a procedure and,

wherein the programmable controller is configured to calculate:

a total blood volume (TBV) for a donor;

a volume of plasma (V P ) to be collected from the donor based on donor-specific characteristics;

a volume of anticoagulant (V ACP ) that will be collected together with the volume of plasma V P ;

a volume of anticoagulant to be returned to the donor (V ACR ) based on an estimated separation efficiency for the separator;

a total volume of anticoagulant (V ACT ) to be used; and

to display V ACT on the touch screen.

21 . The automated system of claim 20 wherein the programmable controller is further configured to make a recommendation as to a total volume of anticoagulant to be attached to the disposable fluid flow circuit based on V ACT , wherein the recommendation is that either a single container or multiple containers are provided that contain 250 ml of anticoagulant, if V ACT <250 ml; 500 ml of anticoagulant, if 250 mL<V ACT <500 ML; 750 ml of anticoagulant, if 500 mL<V ACT <750 mL; and 1000 mL of anticoagulant, if 750 mL<V ACT <1000 mL.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2023
From: MIN, KYUNGYOON
To: FENWAL, INC.
Reel/Frame 064421/0118 →
Continuity (2)
Provisional Application 63141075 · Jan 25, 2021
Related Publication 20240082471A1 · Mar 14, 2024
References Cited (12)
US 5194145A · Schoendorfer · 1993 [cited by applicant]
US 5360542A · Williamson, IV · 1994 [cited by applicant]
US 8840790B2 · Wegener · 2014 [cited by applicant]
US 10046278B2 · Kusters · 2018 [cited by applicant]
US 11386993B2 · Case · 2022 [cited by applicant]
US 20130267884A1 · Boggs · 2013 [cited by examiner]
US 20180344921A1 · Ragusa · 2018 [cited by examiner]
US 20200147289A1 · Patel · 2020 [cited by applicant]
US 20210015989A1 · Patel · 2021 [cited by applicant]
US 20210353841A1 · Patel · 2021 [cited by examiner]
WO 2019226654A1 · 2019 [cited by applicant]
European Search Report and Opinion Issued by the European Patent Office for Application No. 22743164.0, dated Nov. 18, 2024 (11 pages total). [cited by applicant]